ACG 2020 Annual Scientific Meeting

Join GI physicians from around the U.S. and the world for the ACG Annual Scientific Meeting. ACG 2020 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

The ACG 2020 Annual Scientific Meeting is still FREE for ACG members. Attend and earn CME and MOC.


Tuesday, October 27, 2020
6:00 am Registration Open
6:45 am Optional Breakfast Sessions - Choose from 6
(You must register and pay separately for breakfast sessions during the registration process.)

Breakfast G: Minimizing and Managing Endoscopic Complications: Tips and Tricks from the Experts
Moderator: Shivangi T. Kothari, MD, FACG

  • Endoscopic Resection
    Amit Bhatt, MD
    Describe management of complications associated with EMR, ESD, EFTR and STER procedures.
  • ERCP/EUS
    Shivangi T. Kothari, MD, FACG
    Discuss management of common and uncommon complications in ERCP and EUS.
  • Endoscopic Complication Pot-pourri
    TBA
    Identify the various types of endoscopic complications and their optimal management.

Breakfast H: When GI Meets Surgery in IBD – The Severe UC Patient
Moderator: Shannon Chang, MD

  • Steroid Refractory UC
    Jimmy K. Limdi, MD, FACG
    Describe treatments available for steroid refractory ulcerative colitis.
  • Time to Meet the Surgeon
    Jean H. Ashburn, MD
    Discuss key components of the surgical consultation in medically refractory ulcerative colitis.
  • Back to the GI – J-Pouch Complications
    Shannon Chang, MD
    Categorize common complications arising in patients with ileal pouch-anal anastomosis.

Breakfast I: Recent ACG Liver Guidelines
Moderator: Vinay Sundaram, MD

  • Vascular Disorders of the Liver
    Patrick S. Kamath, MD
    Distinguish the different vascular disorders of the liver and recognize management strategies.
  • Hemochromatosis
    Vinay Sundaram, MD
    Evaluate patients for iron overload and describe treatment plans.
  • Alcoholic Liver Disease
    Ashwani K. Singal, MD, MS, FACG
    Explain the different aspects of alcoholic liver disease and summarize the latest guideline recommendations.

Breakfast J: 2020 Hindsight: Where We Have Been and Where We Are GoingModerator: Seth A. Gross, MD, FACG

  • High-Quality Endoscopic Mucosal Resection: When and How
    Christina J. Tofani, MD
    Discuss the appropriate use of EMR, provide practical pearls, and demonstrate the techniques used for EMR.
  • I Should Have Seen It Coming! Preventing and Managing Polypectomy Complications
    TBA
    Explain how to decrease complications of polypectomy, including tips regarding cautery, snares, and prophylactic clipping, and how to manage bleeding and perforations.
  • Today and Tomorrow: Technological Advances That Matter
    Seth A. Gross, MD, FACG
    Identify the hot technology of today and what is around the corner that could change the practice of GI and quality metrics.

Breakfast K: Hey, It’s Legal Now: Cannabinoids and the Gut
Moderator: Ron Schey, MD, FACG

  • Cannabinoid Effects on Motility and Pain
    Ron Schey, MD, FACG
    Differentiate various effects of cannabinoids on the gastrointestinal tract.
  • Cannabinoids: Friend or Foe in Nausea and Vomiting?
    Thangam Venkatesan, MD
    Contrast risk and benefits of cannabinoids in patients with chronic nausea and vomiting.
  • It’s High Time We Learn How to Talk to Patients About Cannabis
    TBA
    Formulate an approach to the discussion of cannabinoids in patients with gastrointestinal symptoms.

Breakfast L: Management Strategies for Eosinophilic Esophagitis
Moderator: Nirmala Gonsalves, MD

  • Medical Management: PPI and Steroid Therapy
    Jennifer Horsley-Silva, MD
    Identify the benefits of each individual approach to therapy in EoE: PPI, topical steroids, or both.
  • Dietary Management: Two, Four or Six Food Elimination?
    Nirmala Gonsalves, MD
    Describe the benefits and burden of different food elimination diets in the management of EOE.
  • Management of Refractory EoE
    Evan S. Dellon, MD, MPH, FACG
    Define refractory EoE and describe potential alternative therapies/approaches to control disease.
8:30 am Annual Scientific Meeting
8:30 am Simultaneous Plenary Sessions 2 - Choose from 2

Plenary Session 2A

  • Papers 19-27

    9 Oral Abstracts – 10 min each (7 min per presentation and 3 min Q & A)

Plenary Session 2B

  • Papers 28-36

    9 Oral Abstracts – 10 min each (7 min per presentation and 3 min Q & A)

10:00 am Exhibit Hall Opens
10:05 am Hands-On Endoscopy Workshop Center Opens
10:05 am J. Edward Berk Distinguished Lecture
Introduced By: Mark B. Pochapin, MD, FACG, ACG President
10:30 am Scientific Poster Session Open
10:35 am Break – Visit the Exhibit Hall and Browse Scientific Posters
10:35 am Exhibitor Theater
11:30 am Simultaneous Symposia Session 3 - Choose from 3

Symposium 3A: Nausea and Vomiting: Evolving Insights and Clinical Challengesy
Moderator: Braden Kuo, MD

  • Practical Insights From the Neurobiology of Nausea and Vomiting
    Braden Kuo, MD
    Describe how the neurobiology of nausea and vomiting influences treatment options.
  • Emerging Treatment: Pharmacologic and Non-Pharmacologic Options for Nausea and Vomiting
    Linda Anh B. Nguyen, MD
    Compare latest treatment strategies for nausea and vomiting.
  • Treatment of Gastroparesis: Beyond the Old Standbys
    Baharak Moshiree, MD, FACG
    Summarize recent pharmacologic and interventional advances in the management of gastroparesis.

Symposium 3B: Endoscopy in 2020 and Beyond: An Update
Moderator: Michael J. Levy, MD (Mayo Rochester)

  • Best Practice Paradigms for Performing a High Quality ERCP
    Vivek Kaul, MD, FACG
    Explain the evidence-based best practice principles for performing a high quality ERCP for optimal patient outcomes.
  • Endoscopic Ultrasound: Current Status and Future Direction
    Michael J. Levy, MD
    Illustrate current and future developments in EUS as they relate to a general GI practice and quality parameters.
  • Bariatric Endoscopy: Strides Made and the Road Ahead
    Violeta B. Popov, MD, PhD, FACG
    Discuss how the field of bariatric endoscopy has evolved and what the future holds, including challenges and opportunities.

Symposium 3C: What’s New With Small Bowel Disorders?
Moderators: Peter H.R. Green, MD, FACG

  • Common Clinical Scenarios Surrounding Celiac Disease
    Peter H.R. Green, MD, FACG
    Differentiate celiac disease from mimicking conditions and define the approach to non-responders on a gluten-free diet.
  • Small Intestinal Bacterial Overgrowth: What’s New?
    Richard J. Saad, MD, FACG
    Discuss the ACG guidelines on diagnosis and treatment of SIBO.
  • Short Bowel Syndrome: An Update
    Carol E. Semrad, MD, FACG
    Identify current challenges in the care of patients with short bowel syndrome and describe treatment strategies.
12:45 pm Lunch Break – Visit Exhibit Hall and Browse Scientific Posters
12:45 pm Exhibitor Theater
1:00 pm Scientific Poster Session – Authors Present
1:40 pm Exhibitor Theater
2:15 pm   Simultaneous Plenary Sessions 3 - Choose from 2

Plenary Session 3A

  • Papers 37-45

    9 Oral Abstracts – 10 min each (7 min per presentation and 3 min Q & A)

Plenary Session 3B

  • Papers 46-54

    9 Oral Abstracts – 10 min each (7 min per presentation and 3 min Q & A)

3:45 pm Break – Visit Exhibit Hall and Browse Scientific Posters
4:30 pm Emily Couric Memorial Lecture - Early Detection of Pancreatic Cancer: Problems, Promise, and Prospects
Introduced by: Mark B. Pochapin, MD, FACG, ACG President
5:00 pm Break
5:10 pm Simultaneous Symposia Session 4 - Choose from 2

Symposium 4A: 50 Shades of Bloating: Multiple Perspectives on a Vexing Condition
Moderator: Kyle D. Staller, MD, MPH

  • It’s All Gas Production: Dietary and Microbial Factors
    Ali Rezaie, MD, MSc
    Recognize the role of gut microbiota and diet in the pathogenesis of bloating.
  • It’s All Hot Air: Bloating Is a Sensory Symptom
    Kyle D. Staller, MD, MPH
    Explain the role of the brain-gut axis in the generation of bloating symptoms.
  • Motility Matters Most!
    Gregory S. Sayuk, MD, MPH
    FACG (UNC Charlotte)
    Appraise the evidence available regarding motility agents in bloating.

Symposium 4B: Recent Developments in Barrett’s Esophagus
Moderator: Nicholas J. Shaheen, MD, MPH, FACG

  • New Tools for Diagnosis
    Gary W. Falk, MD, MS, FACG
    Describe the recent advances in diagnosis and surveillance of Barrett’s, including pre- and post-ablation which may allow for earlier, better detection of dysplasia and cancer.
  • Current Approach to Ablation
    Nicholas J. Shaheen, MD, MPH, FACG
    Discuss the outcomes of studies on RFA/cryoablation for Barrett’s esophagus - dysplastic and non-dysplastic - and the current controversies in treatment of BE.
  • Role of Chemoprevention
    Joel H. Rubenstein, MD, FACG
    Evaluate current chemoprevention options - as well as drugs in the clinical trial stage – aimed at preventing dysplasia and cancer in patients with BE.
6:25 pm Annual Scientific Meeting Adjourns for the day.